In biopharma manufacturing, speed-to-market certainty starts early in preconstruction. Faster project deliveries aren’t achieved by adding more resources in the construction phase. They result from collaborative planning in conjunction with a design that meets the user requirements and schedule parameters. By prioritizing standardization and operational efficiency from the earliest stages, project teams can meet aggressive timelines while navigating procurement constraints and compliance requirements.
Why Standardization Matters
Site-specific designs increase complexity and capital expenditure, and unique specifications can cause maintenance challenges, significant training needs and inventory management. Organizations scale faster when they commit to standardized assets. Standardizing facility design enables portfolio scalability across multiple sites:
- A standardized approach simplifies and accelerates site selection
- Pre-engineered and modular components streamline project starts and local approvals
- Consistent design standards help code navigation, compliance processes and regulatory approvals
- Repeated core elements streamline stakeholder onboarding and expedite procurement
Benefits of Standardization & Planning
While speed-to-market is the end goal, the benefits of standardization extend beyond that.
Financial Benefits: Standardization can save 15–25% in contractor costs by reducing capital expenditure through bulk procurement and repeatable construction.
Operational Efficiency: Consistent layouts and systems cut training time, reduce errors and improve troubleshooting, which can boost efficiency by 25-35%.
Regulatory Agility: Uniform designs simplify upgrades and compliance, lowering regulatory costs by up to 70% and easing technology rollouts.
Speed-to-market is a strategic decision made during the early project planning stages. By standardizing facilities and aligning teams early, biopharma organizations control cost and schedule risks and can better navigate project delivery activities and regulatory complexities. The result is a construction delivery model that achieves the turnover goals and supports flexibility and scalability.
Where We’re Doing It
Consigli’s long-standing partnership with a leading global biopharmaceutical company – spanning more than seven projects over the past decade – demonstrates how upfront planning and standardized design can accelerate speed-to-market across biopharma portfolios. Through early preconstruction activities, modular cleanroom strategies, design-assist collaboration and accelerated procurement, our teams drive faster delivery across sites. On a recent fit-out project, early BIM coordination, off-site prefabrication and strategic equipment procurement enabled construction to start six weeks ahead of a traditional design-bid-build delivery method, reducing risk and positioning the facility for earlier operational readiness.
Contact
Geoff Kramer, Director of Life Science
gkramer@consigli.com | LinkedIn